TCL Archive BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions July 4, 2014
TCL Archive Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show October 30, 2009
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial. June 2, 2000
